News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
AmplifyBio and Xcell Biosciences Collaborate on Manufacturing Solid Tumor-Targeting TCR-T Cell Therapy
Tuesday, May 21, 2024Xcell Biosciences Inc and AmplifyBio have announced a collaborative initiative to enhance the manufacturing process for engineered Tcell receptor therapies targeting solid tumors
Cantex Pharmaceuticals Granted FDA Orphan Drug Status for Azeliragon in Pancreatic Cancer Therapy
Tuesday, May 21, 2024Cantex Pharmaceuticals Inc made an announcement today that the US Food and Drug Administration has granted Orphan Drug Designation to Cantexs azeliragon for treating pancreatic cancer
Virios Therapeutics Prices $1.7 Million Public Offering of Common Stock, Prepares for IMC-2 Long-COVID Phase 2b Study
Monday, May 20, 2024Virios Therapeutics Inc a biotechnology firm focused on developing novel antiviral treatments for chronic illnesses such as fibromyalgia and LongCOVID has disclosed the pricing of its previously
A2 Bio Commences EVEREST-2 Phase 1 Clinical Trial with Initial Patient Administered Novel Mesothelin Logic-Gated CAR T Therapy
Friday, May 17, 2024A Biotherapeutics Inc has initiated the Phase clinical trial for AB marking a significant milestone in the development of its innovative cell therapy This clinicalstage company specializes
Accelerated Biosciences and Spanios Announce Partnership to Improve Therapeutic Approaches for Solid Tumor Cancers
Friday, May 17, 2024Spanios a company known for its unique D tumoroid platforms used to validate solid tumor therapies has announced a new partnership with Accelerated Biosciences Accelerated Biosciences
Aulos Bioscience Collaborates with Merck KGaA, Darmstadt, Germany for Joint Clinical Trial on Bavencio® and AU-007 Combination
Thursday, May 16, 2024Aulos Bioscience a company in immunooncology striving to transform cancer treatment with innovative IL therapeutics has announced a significant collaboration with Ares Trading SA a Swiss subsidiary
Verismo Therapeutics Obtains FDA Clearance for SynKIR™-310 in Relapsed/Refractory B-cell NHL
Wednesday, May 15, 2024Verismo Therapeutics has received approval from the US Food and Drug Administration to proceed with the Phase clinical trial of SynKIR for NHL This trial named CELESTIAL will evaluate the safety
FogPharma and ARTBIO Announce Partnership for the Development of Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies in Cancer Treatment
Wednesday, May 15, 2024FogPharma and ARTBIO Inc are collaborating to develop advanced therapies for various cancers FogPharma renowned for its innovative Helicon peptide platform and ARTBIO
Walden Biosciences Announces Collaboration with Leading Genetic Epidemiologist to Investigate suPAR's Causal Role in Chronic Kidney Disease
Tuesday, May 14, 2024Walden Biosciences Inc a biotechnology company focused on developing therapies for kidney disease has partnered with the Primula Group to utilize genetic data from individuals with chronic kidney disease
TriLink BioTechnologies Partners with Johns Hopkins University to Establish New RNA Innovation Hub
Tuesday, May 14, 2024TriLink BioTechnologies a division of Maravai LifeSciences and a leading global provider of life science reagents and services has announced a collaboration with Johns Hopkins University to accelerate
